Advertisement

Topics

FDA approves Pfizer’s Vizimpro for non-small cell lung cancer

15:35 EDT 10 Oct 2018 | Drug Store News

fda-approves-pfizers-vizimpro-for-non-small-cell-lung-cancer/">

With FDA approval of Vizimpro, Pfizer now offers two medicines that can tackle three different forms of mutation-driven lung cancer.

Read More

Original Article: FDA approves Pfizer’s Vizimpro for non-small cell lung cancer

NEXT ARTICLE

More From BioPortfolio on "FDA approves Pfizer’s Vizimpro for non-small cell lung cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...